Rogier Baak

Rogier Baak is a Radiotherapy Researcher at Erasmus University Rotterdam specializing in stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma through the STRONG trial—a phase I study assessing SBRT safety and feasibility after chemotherapy in unresectable cases.

His research focuses on:

• Radiation Oncology technical delivery
• Cholangiocarcinoma and bile duct carcinoma treatment
• Integration of chemotherapy with radiation therapy
• Clinical trial methodology for phase I safety studies
• Patient outcomes including survival and quality of life

Analysis of his 2021-2023 publications reveals concentrated work on the STRONG trial, emphasizing robotic SBRT precision (addressing breathing motion and dose variations) and clinical metrics like overall survival. The research demonstrates strong collaboration between radiation oncology, medical oncology, and surgical teams to optimize treatment for complex biliary tract cancers.